Opinion

Video

Efficacy and Patient Selection Criteria for PDS with Ranibizumab

Video content above is prompted by the following:

  • What are the benefits of using the PDS with ranibizumab, and which patients are ideal candidates for this delivery method?
  • What do we know about the efficacy of the PDS with ranibizumab from the phase 3 ARCHWAY trial?
Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.